Yankcom Partnership Abb Vie Inc. Transaction History
Yankcom Partnership
- $182 Billion
- Q1 2025
A detailed history of Yankcom Partnership transactions in Abb Vie Inc. stock. As of the latest transaction made, Yankcom Partnership holds 9,539 shares of ABBV stock, worth $1.79 Million. This represents 1.1% of its overall portfolio holdings.
Number of Shares
9,539
Previous 9,708
1.74%
Holding current value
$1.79 Million
Previous $1.73 Billion
15.85%
% of portfolio
1.1%
Previous 0.92%
Shares
2 transactions
Others Institutions Holding ABBV
# of Institutions
4,264Shares Held
1.27BCall Options Held
18.2MPut Options Held
15.5M-
Vanguard Group Inc Valley Forge, PA174MShares$32.6 Billion0.68% of portfolio
-
Black Rock Inc. New York, NY136MShares$25.5 Billion0.54% of portfolio
-
State Street Corp Boston, MA80MShares$15 Billion0.71% of portfolio
-
Jpmorgan Chase & CO New York, NY54.8MShares$10.3 Billion0.9% of portfolio
-
Morgan Stanley New York, NY41.1MShares$7.71 Billion0.63% of portfolio
About AbbVie Inc.
- Ticker ABBV
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,768,099,968
- Market Cap $331B
- Description
- AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...